ZD6474 and Docetaxel in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
This study has been completed.
Jonsson Comprehensive Cancer Center
Information provided by:
First received: February 5, 2003
Last updated: April 7, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||December 2007|
|Primary Completion Date:||September 2004 (Final data collection date for primary outcome measure)|
Heymach JV, Johnson BE, Prager D, Csada E, Roubec J, Pesek M, Spasova I, Belani CP, Bodrogi I, Gadgeel S, Kennedy SJ, Hou J, Herbst RS. Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer. J Clin Oncol. 2007 Sep 20;25(27):4270-7.